Skip to main content

Table 1 Hemodynamic parameters evaluated by invasive measurements.

From: Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats

Group

HR

(beats/min)

LVSP

(mm Hg)

LVEDP

(mm Hg)

dp/dt

(mm Hg/s)

-dp/dt

(mm Hg/s)

Control (n = 8)

347 ± 38

131 ± 18

2.1 ± 0.8

6423 ± 417

5723 ± 331

Diabetes(n = 8)

312 ± 29

101 ± 9*

11.4 ± 3.3*

5396 ± 325*

4321 ± 289*

NRG-1(n = 8)

323 ± 32

118 ± 13#

6.9 ± 2.4*#

5850 ± 387*#

4728 ± 302*#

  1. Values are presented as mean ± SEM; HR: heart rate; LVSP: left ventricle systolic pressure; LVEDP: left ventricle end diastolic pressure; +dp/dt: maximum rate of left ventricle pressure rise; -dp/dt: maximum rate of left ventricle pressure fall; * P ≤ 0.05 vs. control group; # P < 0.05 vs. Diabetic group.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840